Turning Point Therapeutic...

NASDAQ: TPTX · Real-Time Price · USD
75.49
0.09 (0.12%)
At close: Aug 15, 2022, 10:00 PM

Turning Point Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Net Income
-236.55M
Depreciation & Amortization
3.97M
Stock-Based Compensation
58.56M
Other Working Capital
14.38M
Other Non-Cash Items
5.33M
Deferred Income Tax
n/a
Change in Working Capital
14.81M
Operating Cash Flow
-153.88M
Capital Expenditures
-2.43M
Cash Acquisitions
n/a
Purchase of Investments
-439.23M
Sales Maturities Of Investments
447.12M
Other Investing Acitivies
n/a
Investing Cash Flow
5.46M
Debt Repayment
n/a
Common Stock Repurchased
n/a
Dividend Paid
n/a
Other Financial Acitivies
24M
Financial Cash Flow
24M
Net Cash Flow
-124.42M
Free Cash Flow
-156.31M